MAIN


1996-2019 All Rights Reserved. Online Journal of Bioinformatics . You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the  before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJB publications. This article may be copied once but may not be, reproduced or  re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking:To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.


OJBTM

 Online Journal of Bioinformatics  

 Volume 13(2):314-, 2012. 


A virtual PfkB Mycobacterium tuberculosis H37Rv protein

 

Subhalaxmi Nayak (MSc), K. Umadevi (PhD) * and M. Jagannath (MSc)

 

DBT BIF Programme, Department of Marine Living Resources, Andhra University, Visakhapatnam AP, India,

 

ABSTRACT

 

Nayak S, Umadevi K, Jagannath M, A virtual PfkB Mycobacterium tuberculosis H37Rv protein, Onl J Bioinform., Phosphofructokinase B of M. tuberculosis H37Rv (Mtb-PfkB), is a potential drug target due to strong T-cell and IFN-gamma inducing capacity. A PfkB 3D model was generated with crystal structures of 3N1C as a template in Modeller9v9. Structural refinement and energy minimization was done using GROMOS96 43B1 force field and stereochemistry with Procheck, ProSA and PROQ. Active site residues were determined by a complex with substrate inhibitor using Ligplot. Protein-drug docking was applied to detect the binding affinity of this enzyme with published inhibitors natural substrates. Arguslab was used to perform virtual screening of the best-ranked compounds with pharmacokinetics property prediction and receptor-ligand interactions were validated using HEX. Arguslab and Hex Dock results showed that the mutant molecule had more binding energy than the wild type and was more stable. The findings suggested that Ethionamide may inhibit mutant Mtb-PfkB protein

 

Keywords: Mycobacterium tuberculosis H37Rv, Phosphofructokinase B protein, Homology modelling, Virtual Screening, Antibacterial compounds.


MAIN

 

FULL-TEXT (SUBSCRIPTION OR PURCHASE TITLE $25USD)